VNRX Volitionrx Ltd

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: VNRX

Price (delayed)

$0.247

Market cap

$3.37M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.82

Enterprise value

$11.99M

?
Relative Growth: Rel. Growth: 66
Relative Strength: Rel. Strength: 0
Relative Valuation: Rel. Valuation: 29
Relative Profitability: Rel. Profitability: 24
Highlights
The revenue has surged by 86% year-on-year
The gross profit has soared by 86% YoY
VNRX's debt is up by 4.3% YoY but it is down by 2.5% QoQ
The quick ratio has contracted by 12% YoY and by 8% from the previous quarter
Volitionrx's net income has decreased by 10% YoY and by 4.2% from the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.volition.com
Peers: VIVS KEN

Key stats

What are the main financial stats of VNRX

VNRX stock price

How has the Volitionrx stock price performed over time
Intraday
-6.16%
1 week
-10.15%
1 month
-40.75%
1 year
-97.96%
YTD
-95.17%
QTD
-81.7%

Financial performance

How have Volitionrx's revenue and profit performed over time
Revenue
$2.46M
Gross profit
$2.46M
Operating income
-$19.42M
Net income
-$25.64M
Gross margin
100%
Net margin
-1,043.1%
The revenue has surged by 86% year-on-year
The gross profit has soared by 86% YoY
The company's operating margin has surged by 56% YoY and by 10% QoQ
VNRX's net margin is up by 41% YoY but it is down by 4.6% QoQ

Price vs fundamentals

How does VNRX's price correlate with its fundamentals

Growth

What is Volitionrx's growth rate over time

Valuation

What is Volitionrx stock price valuation
P/E
N/A
P/B
N/A
P/S
0.92
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.88
The company's EPS rose by 23% YoY and by 9% QoQ
The stock's P/S is 100% below its 5-year quarterly average of 358.9 and 95% below its last 4 quarters average of 20.5
The revenue has surged by 86% year-on-year

Efficiency

How efficient is Volitionrx business performance
The company's return on sales rose by 43% YoY but it fell by 2.1% QoQ
Volitionrx's ROA has decreased by 40% YoY and by 4.9% from the previous quarter
Volitionrx's return on invested capital has decreased by 29% QoQ

Dividends

What is VNRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for VNRX.

Financial health

How did Volitionrx financials performed over time
The company's total assets is 80% lower than its total liabilities
VNRX's current ratio is down by 14% year-on-year and by 9% since the previous quarter
The quick ratio has contracted by 12% YoY and by 8% from the previous quarter
VNRX's debt is 135% higher than its equity
The company's debt to equity rose by 5% QoQ but it fell by 2.9% YoY
VNRX's debt is up by 4.3% YoY but it is down by 2.5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.